Sintetica
sintetica.com
- Industry
- Pharma & biotech
- Headquarters
- Mendrisio, Ticino
- Type
- private
- Employees (approx.)
- 400
- Checked on
- 19 October 2026
Protection against forged senders: protected
Points per criterion
- MX 10 / 10
- SPF 15 / 15
- DKIM 20 / 20
- DMARC 25 / 25
- DNSSEC 10 / 10
- Transport (MTA-STS/DANE) 0 / 15
- TLS-RPT 0 / 5
- Industry avg.: 65.5 ▲ 14.5
- Canton avg.: 43.3 ▲ 36.7
- Overall avg.: 53.5 ▲ 26.5
- Rank 5 of 24 in the industry
Findings
-
!SPF close to the 10-lookup limit (8)
One more sending service can break the limit. Flattening or subdomains for third parties create headroom.
-
!DKIM key below 2048 bits
RSA-1024 is considered too weak (RFC 8301, M3AAWG). Rotate to 2048-bit keys.
-
!No MTA-STS
Without MTA-STS (or DANE) inbound encryption is not enforced; an attacker on the path can downgrade to plain text.
-
!No TLS reporting (TLS-RPT)
Without TLS-RPT the organisation does not learn when senders fail to deliver encrypted.
Who runs the mail?
- Mailbox provider
- Microsoft 365
- Provider jurisdiction
- USA · MX: US
- Detection confidence
- 100 / 100
- Microsoft tenant
- Managed · Sintetica SA
- Tenant region
- EU
Signals (8)
| MX | Microsoft 365 | sintetica-com.mail.protection.outlook.com |
|---|---|---|
| SPF | Microsoft 365 | include:spf.protection.outlook.com |
| DKIM | Microsoft 365 | selector1 → selector1-sintetica-com._domainkey.sintetica.onmicrosoft.com |
| Autodiscover | Microsoft 365 | autodiscover.outlook.com |
| Domain verification | Microsoft 365 | MS=ms38583991 |
| Network | Microsoft 365 | AS8075 MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation |
| Domain verification | Swiss hoster | protonmail-verification=eb63a7ef3d85d5f7 |
| Entra ID | Microsoft 365 | Entra-ID-Tenant (Managed) |
MX servers
| Pref | Host | IP | Network | Country | TLSA |
|---|---|---|---|---|---|
| 10 | sintetica-com.mail.protection.outlook.com | 52.101.103.137 | AS8075 MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation | US | – |
52.101.68.27 | AS8075 MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation | US | |||
52.101.73.155 | AS8075 MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation | US |
SPF
v=spf1 include:spf.mailjet.com mx include:spf.protection.outlook.com include:sparkpostmail.com include:_spf.salesforce.com a:smtpauth.vertigoconsulting.it ip4:195.141.59.128/28 ip4:195.141.183.192/28 ip4:212.47.178.48/28 ip4:212.47.178.224/28 -all - all
-all- DNS lookups
- 8 / 10
- Includes
spf.mailjet.comspf.protection.outlook.comsparkpostmail.com_spf.salesforce.com- Detected sending services
- Mailjet, Microsoft 365, SparkPost, Salesforce
- IPv4
- 64 addresses authorised directly
DMARC
v=DMARC1; p=reject; rua=mailto:it@sintetica.com; ruf=mailto:it@sintetica.com - Policy
- p=reject
- Subdomains (sp)
- inherits p=reject
- Share (pct)
- 100 %
- Alignment DKIM/SPF
- relaxed / relaxed
- Aggregate reports (rua)
it@sintetica.com- Forensic reports (ruf)
it@sintetica.com
DKIM
| Selector | Key | delegated to |
|---|---|---|
k2 | RSA 2048 | dkim2.mcsv.net |
k3 | RSA 2048 | dkim3.mcsv.net |
mailjet | RSA 1024 | – |
selector1 | RSA 1024 | selector1-sintetica-com._domainkey.sintetica.onmicrosoft.com |
sf1 | RSA 2048 | sf1.qnj696.custdkim.salesforce.com |
sf2 | RSA 2048 | sf2.fvoa2f.custdkim.salesforce.com |
Checked: 100 common selectors. Keys under custom selectors remain invisible.
Transport encryption
- MTA-STS
- missing
- DANE
- missing
- DNSSEC
- active
- TLS-RPT
- missing
- BIMI
- missing
Verified services
From verification records in the domain TXT: services where the domain is verified.
Microsoft 365GlobalSign
History
- Score 80 · DMARC reject
Raw data
sintetica.com. IN MX 10 sintetica-com.mail.protection.outlook.com.
sintetica.com. IN TXT "v=spf1 include:spf.mailjet.com mx include:spf.protection.outlook.com include:sparkpostmail.com include:_spf.salesforce.com a:smtpauth.vertigoconsulting.it ip4:195.141.59.128/28 ip4:195.141.183.192/28 ip4:212.47.178.48/28 ip4:212.47.178.224/28 -all"
_dmarc.sintetica.com. IN TXT "v=DMARC1; p=reject; rua=mailto:it@sintetica.com; ruf=mailto:it@sintetica.com" More from this industry
- Octapharma 87
- Roche 87
- Debiopharm 80
- Siegfried 80
- Cerbios-Pharma 74
- Bachem 70
- Galderma 70
- Novartis 70